Royce & Associates LP Artivion, Inc. Transaction History
Royce & Associates LP
- $8.75 Billion
- Q1 2025
A detailed history of Royce & Associates LP transactions in Artivion, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 687,420 shares of AORT stock, worth $21.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
687,420
Previous 831,000
17.28%
Holding current value
$21.1 Million
Previous $23.9 Million
29.35%
% of portfolio
0.19%
Previous 0.23%
Shares
31 transactions
Others Institutions Holding AORT
# of Institutions
187Shares Held
38.6MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$204 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$89.2 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$85.8 Million2.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.78MShares$85.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.26MShares$69.4 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.24B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...